A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a midstage study. Subjects taking Amgen’s MariTide lost 20% of their body weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback